Assessment the Levels of Serum Ferritin and Some Biochemical Parameters in Type 2 Diabetic Subjects Attending A Tertiary Hospital in Bangladesh
Md. AshiqurRahman
Lab. Scientific Officer, Novus Clinical Research Services Limited (NCRSL), Bangladesh
Sadia Islam
Junior Scientific Officer, Bangladesh Specialized Hospital Limited (BSHL), Bangladesh
Shohanur Rahaman
Scientific Officer, Diabetic Association of Bangladesh (BADAS), Bangladesh
Md. RajibEmran
Scientific Officer, Delta Medical College & Hospital, Bangladesh
DOI: https://doi.org/10.59429/mmr.v1i1.137
Keywords: Serum ferritin; DM; Iron; HbA1c
Abstract
Background: Type 2 diabetes (NIDDM) is the commonest form of diabetes constituting nearly 90% of the diabetic population in any country. Iron is an important mineral in normal physiological processes, and ferritin is a specialized iron storage protein, which reflects iron stores in the body. Iron overload is a risk factor for diabetes. The link between iron and diabetes was first recognized in pathologic conditions-hereditary hemochromatosis and thalassemia, but high levels of dietary iron also import diabetes risk. Iron plays a direct and causal role in diabetes pathogenesis mediated both by β-cell failure and insulin resistance. The objective of the study to evaluate serum ferritin level among type 2 diabetes patients. Method: A hospital based observational study a total of 240 subjects among them 60 male diabetes patients and 60 female diabetes patients were recruited. Serum ferritin level were checked in all participants. Results: The mean age of T2DM was 59 14 years and control group was 50 13 years. The BMI of each group was 27.52 2.6 and 24.80 2.4. Ferritin (ng/dL) level in T2 DM subjects was 231 36 and control subjects was 48 22. Serum ferritin level among the study subjects control vs T2 DM, t/p value (8.465/0.0001). Conclusion: From this study it was observed that ferritin level is significantly higher among type 2 diabetes patients.
References
1. Vinik A, Flemmer M. Diabetes and macrovascular disease. Journal of Diabetes and its Complications 2002; 16(3): 235–245.
2. Sultanpur CM, Deepa K, Kumar SV. Comprehensive review on HbA1c in diagnosis of diabetes mellitus. International Journal of Pharmaceutical Sciences Review and Research 2010; 3(2): 119–122.
3. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New England Journal of Medicine 2003; 348(5): 383–393. doi: 10.1056/NEJMoa021778
4. The diabetes control and complications trial research group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. New England Journal of Medicine 1993; 329: 977–986. doi: 10.1056/NEJM199309303291401
5. Mohiuddin A. Diabetes fact: Bangladesh perspective. Community and Public Health Nursing 2019; 4(1): 39.
6. Raj S, Rajan GV. Correlation between elevated serum ferritin and HbA1c in type 2 diabetes mellitus. International Journal of Research in Medical Sciences 2013; 1(1): 12–15. doi: 10.5455/2320-6012.ijrms20130203
7. Kunutsor SK, Apekey TA, Walley J, Kain K. Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta‐analysis of prospective evidence. Diabetes/metabolism Research and Reviews 2013; 29(4): 308–318. doi: 10.1002/dmrr.2394
8. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among US adults. Diabetes Care 1999; 22(12): 1978–1983. doi: 10.2337/diacare.22.12.1978
9. Raj S, Rajan GV. Correlation between elevated serum ferritin and HbA1c in type 2 diabetes mellitus. International Journal of Research in Medical Sciences 2013; 1(1): 12–15. doi: 10.5455/2320-6012.ijrms20130203
10. Elimam H, Abdulla AM, Taha IM. Inflammatory markers and control of type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(1): 800–804.
11. Islam S, Hossen MA, Rahman MA, Lubaba MI, Akram A. Serum uric acid level among type-2 diabetes subjects attending in a tertiary hospital of Bangladesh. World Journal of Biology Pharmacy and Health Sciences. 2022;12(1):081-5.
12. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among US adults. Diabetes Care 1999; 22(12): 1978–1983. doi: 10.2337/diacare.22.12.1978
13. Rahman MA, Islam S, Lubaba MS, Akram A. Study of Uric acid and Serum Creatinine in Diabetic and Non-Diabetic patients in a tertiary hospital, Dhaka. Int. j. adv. multidisc. res. stud. 2022; 2(6):226-228.
14. Andrews M, Soto N, Arredondo-Olguín M. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity. Nutrition 2015; 31(1): 51–57. doi: 10.1016/j.nut.2014.04.019
15. Chen L, Li Y, Zhang F, et al. Elevated serum ferritin concentration is associated with incident type 2 diabetes mellitus in a Chinese population: A prospective cohort study. Diabetes Research and Clinical Practice 2018; 139: 155–162. doi: 10.1016/j.diabres.2018.03.001
16. Amiruzzaman M, Roy MN, Lopa AR, Chanda M, Rahman MA, Akram A. Association of Serum Gamma-Glutamyl Transferase Level with Metabolic Syndrome and Insulin Resistance in Adults.
17. Fatema K, Rahman MA, Ahmed ANN, Paul D, Mondal BR, Islam S, Khatun DR, Akram A. Salivary Ferritin is a Diagnostic Marker in Iron Deficiency Anaemia in Children. Int. j. adv. multidisc. res. stud. 2022; 2(6):913-918.